Oncologist Beth Overmoyer on Inflammatory Breast Cancer
Beth Overmoyer, a breast oncologist at the Susan F. Smith Center for Women's Cancer's at Dana-Farber in Boston, provides a brief overview of inflammatory breast cancer.
PUBLISHED February 10, 2015
Beth Overmoyer, a breast oncologist at the Susan F. Smith Center for Women’s Cancer’s at Dana-Farber in Boston, provides a brief overview of women likely to be diagnosed with inflammatory breast cancer, and the need for a better understanding of the disease.
Inflammatory breast cancer is found in both premenopausal and postmenopausal women. Overmoyer says the biology of inflammatory breast cancer differs from other types of breast cancer. Clinical presentations of the disease are often missed by both practitioners and patients. A poster session at the 2014 San Antonio Breast Cancer Symposium provided attendees with the opportunity to explore inflammatory breast cancer, its epidemiology and its outcomes.